AYTU BIOPHARMA, INC Foreign Currency Transaction Gain (Loss), Realized
AYTU BIOPHARMA, INC (AYTU) reported Foreign Currency Transaction Gain (Loss), Realized of $765 for the 12-month period ending 2010-08-31, per its 10-K filed 2014-11-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2014-11-26
- AYTU BIOPHARMA, INC foreign currency transaction gain (loss), realized for fiscal 2010 was $765.00.
- AYTU BIOPHARMA, INC foreign currency transaction gain (loss), realized for fiscal 2009 was -$1.21K, a 3893.75% decline from fiscal 2008.
- AYTU BIOPHARMA, INC foreign currency transaction gain (loss), realized for fiscal 2008 was $32.00, a 92.33% decline from fiscal 2007.
- AYTU BIOPHARMA, INC foreign currency transaction gain (loss), realized for fiscal 2007 was $417.00.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|
| 2010-08-31 | $765.00 10-K · filed 2014-11-26 |
| 2009-08-31 | -$1.21K 10-K · filed 2014-11-26 |
| 2008-08-31 | $32.00 10-K · filed 2014-11-26 |
| 2007-08-31 | $417.00 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |